Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


07.07.2025

4 BMC Neurol
2 Curr Opin Immunol
1 Intern Med
1 J Autoimmun
2 J Immunol
1 J Neuroimmunol
6 J Neurol
7 J Rheumatol
2 Kidney Int
2 Mult Scler
1 Neurol Clin Pract
1 Neurology
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. TOKER OG, Kuru E, Tas Elibol N, Guzel V, et al
    Spectral resolution and speech comprehension performance in noise in individuals with multiple sclerosis.
    BMC Neurol. 2025;25:257.
    PubMed         Abstract available

  2. ZHANG H, Yang J, Zhang X, Wu C, et al
    A novel gene signature for forecasting time to next relapse in multiple sclerosis using peripheral blood mononuclear cells.
    BMC Neurol. 2025;25:261.
    PubMed         Abstract available

  3. SU B, He Z, Shi L, Li M, et al
    Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study.
    BMC Neurol. 2025;25:271.
    PubMed         Abstract available

  4. DEHGHANI A, Keshavarzi A, Pourfarid Y
    Development and validation of the antecedents affecting coping questionnaire in patients with multiple sclerosis.
    BMC Neurol. 2025;25:254.
    PubMed         Abstract available


    Curr Opin Immunol

  5. FAN S, Pruss H
    Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
    Curr Opin Immunol. 2025;95:102594.
    PubMed         Abstract available

  6. XU Y, Yi X, Li C, Chen J, et al
    CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
    Curr Opin Immunol. 2025;95:102600.
    PubMed         Abstract available


    Intern Med

  7. TSUZUKI WADA T, Yokota K, Okada M, Ichimura T, et al
    Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic Multicentric Castleman Disease Successfully Treated with Tocilizumab.
    Intern Med. 2025;64:2073-2079.
    PubMed         Abstract available


    J Autoimmun

  8. PIREDDU MP, Rizzo G, Congiu F, Chessa E, et al
    Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus.
    J Autoimmun. 2025;155:103455.
    PubMed         Abstract available


    J Immunol

  9. JIANG K, Xu Y, Wang Y, Yin N, et al
    Deciphering the role of IL-17D, its newly identified receptor CD93, and IL-17D-CD93 axis in health and disease.
    J Immunol. 2025;214:1113-1122.
    PubMed         Abstract available

  10. ZHEN Y, Shao WH
    WDFY1-expressing follicular dendritic cells play a critical role in lupus development in cGVHD mouse model.
    J Immunol. 2025;214:1160-1172.
    PubMed         Abstract available


    J Neuroimmunol

  11. NIBBER A, Wills B, Pettingill P, Fox H, et al
    Evolution and significance of neuronal surface autoantibodies after Japanese encephalitis.
    J Neuroimmunol. 2025;406:578671.
    PubMed         Abstract available


    J Neurol

  12. VERCELLINO M, Marasciulo S, Bosa C, Rolando A, et al
    Added value of spinal cord MRI in detecting active disease in non-relapsing progressive multiple sclerosis patients.
    J Neurol. 2025;272:482.
    PubMed         Abstract available

  13. ZACCONE T, Moiola L, Guerrieri S, Nozzolillo A, et al
    Long-term effectiveness and safety of ocrelizumab: a single-centre real-world study.
    J Neurol. 2025;272:481.
    PubMed         Abstract available

  14. LIMA SM, Rini N, Cali A, Brighina F, et al
    Clonidine for the management of crises in stiff-person syndrome.
    J Neurol. 2025;272:485.
    PubMed         Abstract available

  15. VAN TILBURG SJ, Kocer S, Geissler J, van Rijs W, et al
    Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barre syndrome.
    J Neurol. 2025;272:487.
    PubMed         Abstract available

  16. WANG Y, Nao J, Duan Y, Li Z, et al
    Therapeutic strategies targeting complement in myasthenia gravis patients.
    J Neurol. 2025;272:489.
    PubMed         Abstract available

  17. CAGOL A, Schaedelin S, Ocampo-Pineda M, Benkert P, et al
    Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.
    J Neurol. 2025;272:491.
    PubMed         Abstract available


    J Rheumatol

  18. SMITH JD, Pan B, Keeling S
    Identifying the State of Mental Health Care in Canadian Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089.
    PubMed         Abstract available

  19. JUNEK ML, Okaj I, Patel S, Hu A, et al
    Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic review and meta-analysis.
    J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204.
    PubMed         Abstract available

  20. COHEN-HAGAI K, Saban M, Benchetrit S, Bar-Ziv D, et al
    Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic Lupus Erythematosus Patients with and without Lupus Nephritis.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087.
    PubMed         Abstract available

  21. TEAW S, Shojaee A, Carnaru M, Hinchcliff M, et al
    The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon.
    J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954.
    PubMed        

  22. KHAROUF F, Mehta P, Li Q, Gladman DD, et al
    Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on Presentation and Outcomes in an Inception Cohort.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278.
    PubMed         Abstract available

  23. KHAROUF F, Mehta P, Alhadri A, Li Q, et al
    Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302.
    PubMed         Abstract available

  24. PATEL H, DeMasters D, Tofferi J
    Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
    J Rheumatol. 2025;52:721-727.
    PubMed         Abstract available


    Kidney Int

  25. MASOUD S, Wong K, Pitcher D, Downward L, et al
    Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranous proliferative glomerulonephritis using the United Kingdom RaDaR Registry.
    Kidney Int. 2025 Jun 27:S0085-2538(25)00491-0. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available

  26. FLOEGE J, Lafayette R, Barratt J, Schwartz B, et al
    Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy.
    Kidney Int. 2025 Jun 26:S0085-2538(25)00488-0. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available


    Mult Scler

  27. AFFINITO G, Moccia M, Lanzillo R, Marrie RA, et al
    Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare data.
    Mult Scler. 2025 Jul 3:13524585251347513. doi: 10.1177/13524585251347513.
    PubMed         Abstract available

  28. CRUZ RIVERA S, Buxhoeveden S, Aiyegbusi OL, Bozinov N, et al
    The importance of patient-reported outcomes: A call for their integration in the routine care of patients with multiple sclerosis.
    Mult Scler. 2025 Jun 29:13524585251349354. doi: 10.1177/13524585251349354.
    PubMed         Abstract available


    Neurol Clin Pract

  29. MCLAREN NP, Roy B, Nowak RJ
    Understanding Racial and Ethnic Disparities in Myasthenia Gravis Outcomes: EXPLORE-MG Registry Experience.
    Neurol Clin Pract. 2025;15:e200503.
    PubMed         Abstract available


    Neurology

  30. NEWSOME SD, Krzystanek E, Selmaj KW, Dufek M, et al
    Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study.
    Neurology. 2025;105:e213909.
    PubMed        


    PLoS One

  31. TAKAHASHI K, Takeishi C, Tsutsumi C, Nakao T, et al
    Exploring the relationship between self-care agency and quality of life in adults with diabetes: A cross-sectional study.
    PLoS One. 2025;20:e0326783.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.